China Universal Asset Management Co., Ltd. Summit Therapeutics Inc. Transaction History

China Universal Asset Management Co., Ltd.

$1.17 Billion
Q3 2025

A detailed history of China Universal Asset Management Co., Ltd. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 130,210 shares of SMMT stock, worth $2.38 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

130,210

Previous 149,162 12.71%

Holding current value

$2.38 Million

Previous $3.17 Million 14.97%

% of portfolio

0.23%

Previous 0.31%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$17.61 - $30.02 $333,744 - $568,939	-18,952 Reduced 12.71%	130,210 $2.7 Million
Q2 2025 Aug 28, 2025	BUY	$16.64 - $36.7 $19,901 - $43,893	1,196 Added 0.81%	149,162 $3.17 Million
Q1 2025 Apr 29, 2025	SELL	$16.65 - $23.76 $139,860 - $199,584	-8,400 Reduced 5.37%	147,966 $2.85 Million
Q4 2024 Jan 23, 2025	BUY	$17.52 - $23.46 $298,085 - $399,148	17,014 Added 12.21%	156,366 $2.79 Million
Q3 2024 Oct 25, 2024	BUY	$6.89 - $31.93 $391,896 - $1.82 Million	56,879 Added 68.97%	139,352 $3.05 Million
Q2 2024 Jul 19, 2024	SELL	$2.39 - $10.92 $125,169 - $571,902	-52,372 Reduced 38.84%	82,473 $643,000
Q1 2024 Apr 29, 2024	BUY	$2.55 - $5.07 $137,123 - $272,634	53,774 Added 66.33%	134,845 $558,000
Q4 2023 May 21, 2024	SELL	$1.67 - $2.83 $89,802 - $152,180	-53,774 Reduced 39.88%	81,071 $211,000
Q4 2023 Jan 23, 2024	BUY	$1.67 - $2.83 $105,490 - $178,765	63,168 Added 352.83%	81,071 $212,000
Q3 2023 May 21, 2024	BUY	$1.54 - $2.42 $13,487 - $21,194	8,758 Added 95.77%	17,903 $33,000
Q3 2023 Oct 30, 2023	BUY	$1.54 - $2.42 $13,487 - $21,194	8,758 Added 95.77%	17,903 $33,000
Q2 2023 May 21, 2024	SELL	$1.32 - $2.81 $406 - $865	-308 Reduced 3.26%	9,145 $22,000
Q2 2023 Jul 27, 2023	SELL	$1.32 - $2.81 $406 - $865	-308 Reduced 3.26%	9,145 $23,000
Q1 2023 May 21, 2024	BUY	$1.38 - $5.41 $10,223 - $40,077	7,408 Added 362.25%	9,453 $16,000
Q1 2023 Apr 27, 2023	BUY	$1.38 - $5.41 $10,223 - $40,077	7,408 Added 362.25%	9,453 $17,000
Q4 2022 May 21, 2024	SELL	$0.68 - $5.31 $90,304 - $705,168	-132,800 Reduced 98.48%	2,045 $8,000
Q4 2022 Jan 31, 2023	BUY	$0.68 - $5.31 $108 - $849	160 Added 8.49%	2,045 $9,000
Q3 2022 Oct 21, 2022	BUY	$0.89 - $1.63 $1,677 - $3,072	1,885 New	1,885 $2,000

Others Institutions Holding SMMT

# of Institutions

268

Shares Held

94.6M

Call Options Held

4.72M

Put Options Held

4.03M

View Full List

About Summit Therapeutics Inc.

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.67B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

More about SMMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account

China Universal Asset Management Co., Ltd. Summit Therapeutics Inc. Transaction History